Literature DB >> 35699812

ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.

J C Chen1, Jose G Bazan2, Samilia Obeng-Gyasi3.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35699812     DOI： 10.1245/s10434-022-12016-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  2 in total

1.  Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.

Authors:  Catherine L Akay; Naoto T Ueno; Gary B Chisholm; Gabriel N Hortobagyi; Wendy A Woodward; Ricardo H Alvarez; Isabelle Bedrosian; Henry M Kuerer; Kelly K Hunt; Lei Huo; Gildy V Babiera
Journal:  Cancer       Date:  2014-02-07       Impact factor: 6.860

Review 2.  Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.

Authors:  Arjun Menta; Tamer M Fouad; Anthony Lucci; Huong Le-Petross; Michael C Stauder; Wendy A Woodward; Naoto T Ueno; Bora Lim
Journal:  Surg Clin North Am       Date:  2018-05-24       Impact factor: 2.741
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.